MovieTK Launches the Future of Streaming — Entertainment + Income in One PlatformAward-winning films, international content, and a unique VIP Program that lets viewers earn.
NUTX INVESTORS: Kirby McInerney LLP Reminds Nutex Health Inc. Investors of Important Deadline in Class Action LawsuitNEW YORK, Oct. 03, 2025 (GLOBE NEWSWIRE) -- If you have suffered a loss on your Nutex Health Inc. (“Nutex” or the “Company”) (
NASDAQ:NUTX) investment, contact Thomas W. Elrod of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below to discuss your rights or interests in the securities fraud class action lawsuit at no cost.
LGI Homes Reports September and Third Quarter 2025 Home Closings and Announces Date for Third Quarter Earnings Conference CallTHE WOODLANDS, Texas, Oct. 03, 2025 (GLOBE NEWSWIRE) -- LGI Homes, Inc. (
NASDAQ: LGIH) today announced it closed 354 homes in September 2025, which includes the closing of 28 currently or previously leased single-family rental homes. For the third quarter 2025, we closed a total of 1,107 homes including the closing of 42 currently or previously leased single-family rental homes.
Aptera Motors Corp. Registration Statement Now Effective with the SEC – Shareholders May Begin Broker TransfersCARLSBAD, Calif., Oct. 03, 2025 (GLOBE NEWSWIRE) -- Aptera Motors Corp. is pleased to announce that its registration statement was declared effective by the U.S. Securities and Exchange Commission (SEC) on September 30, 2025. This important milestone enables Aptera shareholders to transfer their Class B common stock from Computershare, the company’s transfer agent, to their brokerage accounts using the Direct Registration System (DRS). The effectiveness of the registration statement does not mean Aptera shares are trading or publicly listed on an exchange. The company is actively coordinating with Nasdaq to finalize our public listing date. While the exact timing remains under discussion, we can confirm that the listing will not occur before October 14, 2025. This window ensures shareholders have sufficient time to complete transfers into their brokerage accounts. Once the date is confirmed, we will announce it in advance via press release to ensure all stakeholders are appropriately informed.
Novacap Announces Partnership with FyberCom to Accelerate Fiber Expansion in IdahoMONTREAL and IDAHO FALLS, Idaho, Oct. 03, 2025 (GLOBE NEWSWIRE) -- Novacap, a leading North American private equity firm, is pleased to announce that it has successfully closed its investment in FyberCom. The transaction marks the sixth platform investment by Novacap’s Digital Infrastructure Sector.
Prime Mining Receives Final Order for Arrangement with TorexVANCOUVER, British Columbia, Oct. 03, 2025 (GLOBE NEWSWIRE) -- Prime Mining Corp. (“Prime” or the “Company”) (TSX: PRYM) (OTCQX: PRMNF) (Frankfurt: O4V3) is pleased to announce that the Supreme Court of British Columbia has granted the final order in connection with the Company's plan of arrangement (the "Arrangement") with Torex Gold Resources Inc. ("Torex"), whereby Torex will, among other things, acquire all of the issued and outstanding common shares of the Company (the “Prime Shares”). Pursuant to the Arrangement, shareholders of Prime (“Shareholders”) will receive 0.060 of a common share of Torex for each Prime Share held.
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NOVATO, Calif., Oct. 03, 2025 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (
NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for rare and ultra-rare diseases, today reported the grant of non-qualified stock options to purchase an aggregate of 62,232 shares of common stock of the company and 34,564 restricted stock units of the company’s common stock to one newly hired non-executive officer employee of the company. The awards were approved by the compensation committee of the company’s board of directors and granted under the Ultragenyx Employment Inducement Plan, with a grant date of September 30, 2025, as an inducement material to the new employee entering into employment with Ultragenyx in accordance with Nasdaq Listing Rule 5635(c)(4).
Innovator ETFs Trust Announces Revised Net Asset Value Information for Innovator Index Autocallable Income Strategy ETF (NYSE Arca: ACII)WHEATON, Ill., Oct. 03, 2025 (GLOBE NEWSWIRE) -- Innovator Capital Management, LLC (Innovator) announces that the net asset value (NAV) per share of the Innovator Index Autocallable Income Strategy ETF (NYSE Arca: ACII) for September 25, 2025, was adjusted by the amount indicated below on October 3, 2025. This adjustment is a result of an error in calculating ACII’s NAV.
National Organization on Disability Recognizes 2025 Leading Disability EmployersWashington, DC, Oct. 03, 2025 (GLOBE NEWSWIRE) -- In celebration of National Disability Employment Awareness Month, the National Organization on Disability (NOD) is honored to recognize nearly 40 companies as the NOD Leading Disability Employers for 2025. This award formally acknowledges companies with the highest performance in disability inclusion practices and policies, benchmarked against dozens of participating organizations.
Context Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)PHILADELPHIA, Oct. 03, 2025 (GLOBE NEWSWIRE) -- Context Therapeutics Inc. (“Context” or the “Company”) (Nasdaq: CNTX), a clinical-stage biopharmaceutical company advancing T cell engaging bispecific antibodies for solid tumors, today announced that Context has granted non-qualified stock option awards to purchase 30,000 shares of its common stock to a new employee as an inducement material for accepting employment with Context.
RENPHO and Mike Bako, tech analyst, preview Prime Big Deal Days with YourUpdateTVMike Bako Discusses How RENPHO Leads the Way in Self-Care and Wellness with Best-Selling Amazon Innovations
Diginex Announces Completion of Acquisition of Matter DK ApS, Strengthening Diginex’s AI-driven ESG Data and Analytics LeadershipLONDON, Oct. 03, 2025 (GLOBE NEWSWIRE) -- Diginex Limited (
NASDAQ: DGNX) (“Diginex”), a leading provider of Sustainability RegTech, today announced the closing of the all-share acquisition of Matter DK ApS (“Matter”), an innovative ESG data company focused on delivering sustainability data, analytics, and insights to the investment industry, which occurred on October 3, 2025. The acquisition enhances Diginex’s capabilities in ESG data benchmarking, reporting, and AI-driven analytics, enabling more comprehensive solutions for clients navigating global sustainability regulations and stakeholder demands. Matter, headquartered in Copenhagen, Denmark, brings advanced tools including an intuitive analytics platform for portfolio-level sustainability analysis, flexible API integrations powering platforms like Nasdaq eVestment, and traceable, granular ESG datasets aligned with SDGs and regulatory frameworks.
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)PALO ALTO, Calif., Oct. 03, 2025 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a new type of biopharmaceutical company focused on genetic diseases, today announced that on October 2, 2025, the compensation committee of BridgeBio’s board of directors approved equity grants to 11 new employees in restricted stock units for an aggregate of 23,884 shares of the Company’s common stock. One-fourth of the shares underlying each employee’s restricted stock units will vest on November 16, 2026, with one-twelfth of the remaining shares underlying each such employee’s restricted stock units vesting on a quarterly basis thereafter, in each case, subject to each such employee’s continued employment with the Company or one of its subsidiaries on such vesting dates. All of the above-described awards were made under BridgeBio’s Amended and Restated 2019 Inducement Equity Plan (the “Plan”).
Vor Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)CAMBRIDGE, Mass., Oct. 03, 2025 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today announced that, on September 19, 2025, the Compensation Committee of the Board of Directors granted stock options to purchase an aggregate of 76,360 shares of Vor Bio’s common stock and restricted stock units (“RSUs”) representing the right to receive an aggregate of 16,361 shares of Vor Bio’s common stock to eight newly hired employees. The foregoing stock options and RSUs were granted as material inducements to employment with Vor Bio in accordance with Nasdaq Listing Rule 5635(c)(4) and were granted under the Vor Biopharma Inc. 2023 Inducement Plan (the “Inducement Plan”).
BTC Development Corp. Completes $253 Million Initial Public OfferingPHILADELPHIA, PA, Oct. 03, 2025 (GLOBE NEWSWIRE) -- BTC Development Corp. (
NASDAQ: BDCIU) (the “Company”) today announced the closing of its initial public offering of 25,300,000 units, which includes 3,300,000 units issued pursuant to the exercise by the underwriters of their over-allotment option in full. The offering was priced at $10.00 per unit, resulting in gross proceeds of $253,000,000.
Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)NEW YORK, Oct. 03, 2025 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, today announced that on October 1, 2025 the Company granted inducement awards to purchase up to 138,900 shares of common stock to 10 new employees under the Company's 2023 Inducement Plan. The stock options will vest over four years, with 25% of the underlying shares vesting on the one-year anniversary of the vesting commencement date and 1/48th of the underlying shares vesting monthly thereafter over 36 months, subject to the employee's continued service relationship with Syndax through the applicable vesting dates.
First Hawaiian to Report Third Quarter 2025 Financial Results on October 24, 2025HONOLULU, Oct. 03, 2025 (GLOBE NEWSWIRE) -- First Hawaiian, Inc. (
NASDAQ: FHB) announced today that it plans to release its third quarter 2025 financial results on Friday, October 24, 2025 before the market opens. First Hawaiian will host a conference call to discuss the company’s results on the same day at 1:00 p.m. Eastern Time (7:00 a.m. Hawaii Time).
Cosmos Health Expands Sky Premium Life Into $1Bn+ Kuwait Market; Signs Exclusive Distribution Agreement With Diyar United and Secures Initial Purchase Order of Over 65,000 UnitsCHICAGO, Oct. 03, 2025 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (
NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that its subsidiary, SkyPharm S.A., has entered into an exclusive distribution agreement, dated as of September 28, 2025, with Diyar United for the marketing and sale of its Sky Premium Life® line of nutraceuticals in Kuwait.
SEMLER CLASS ACTION ALERT: Bragar Eagel & Squire, P.C. Reminds Investors of the October 28th Deadline in the Class Action Lawsuit Filed Against Semler Scientific, Inc.Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Semler (SMLR) To Contact Him Directly To Discuss Their Options
FREEPORT ALERT: Bragar Eagel & Squire, P.C. is Investigating Freeport-McMoran Inc. on Behalf of Freeport Stockholders and Encourages Investors to Contact the FirmBragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Freeport (FCX) To Contact Him Directly To Discuss Their Options
Datavault AI Selected to Power First Tokenized Dream Bowl XIV and Esports Global Championships on Jan. 11 at AT&T Stadium in Arlington, TXPartnerships with Cutting Edge Sports Management and FN Esports showcase Datavault’s ADIO® and VerifyU® technologies in college football, Madden and team esports, and drone racing championships.
AAC&U Statement on the Trump Administration’s “Compact for Academic Excellence in Higher Education”Washington, DC, Oct. 03, 2025 (GLOBE NEWSWIRE) -- In April, leaders of America’s colleges, universities, and scholarly societies called for constructive engagement with government in response to unprecedented overreach and political interference in higher education—expressing openness to constructive reform and acceptance of legitimate government oversight, while also affirming the core principles, shared values, and established legal framework on which the American system of higher education rests.
1847 Holdings Expects to Resume Trading on OTC Pink Limited TierCompany reaffirms its intention to relist on a senior U.S. exchange as soon as practical
Experience Columbus Launches New Columbus Booklovers Trail During National Book MonthColumbus, Ohio, Oct. 03, 2025 (GLOBE NEWSWIRE) -- Just in time for National Book Month, Experience Columbus invites readers to explore Ohio's capital city in a new way with the Columbus Booklovers Trail. This free, self-guided digital pass showcases local independent bookstores, comic shops, libraries and attractions, giving locals and visitors a chance to discover the city's rich literary history and earn a Columbus Booklovers Trail sweatshirt upon completion.
ACG Metals Limited to Present at the Metals & Mining Virtual Investor Conference October 7thCompany invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com
UNICYCIVE LAWSUIT ALERT: Bragar Eagel & Squire, P.C. Reminds Investors in Unicycive to Contact the Firm Regarding Filed Class Action Lawsuit Before October 14thBragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Unicycive (UNCY) To Contact Him Directly To Discuss Their Options Before the October 14th Deadline.
Transaction in Own SharesTransaction in Own Shares
LIFEMD LAWSUIT ALERT: Bragar Eagel & Squire, P.C. Reminds LifeMD Investors to Contact the Firm Before the October 27th Deadline Regarding Class Action LawsuitBragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In LifeMD (LFMD) To Contact Him Directly To Discuss Their Options
SNAP LAWSUIT REMINDER: Bragar Eagel & Squire, P.C. Urges Snap, Inc. Investors to Contact the Firm Before October 20th to Inquire About their RightsBragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Snap (SNAP) To Contact Him Directly To Discuss Their Options
250th Anniversary United States Navy American Eagle One Ounce Silver Proof Coin Available on October 10WASHINGTON, D.C., Oct. 03, 2025 (GLOBE NEWSWIRE) -- The United States Mint (Mint) will begin accepting orders for the 250th Anniversary United States Navy American Eagle One Ounce Silver Proof Coin (product code 25NPM) on Friday, October 10 at noon EDT. The coin includes a special privy mark on its obverse, depicting the United States Navy emblem and honoring its 250th anniversary. Orders are limited to one coin per household for the first 24 hours of sales.
Smith+Nephew announce latest scientific data supporting new ALLEVYN™ COMPLETE CARE 5-Layer Foam Dressing for pressure injury preventionSmith+Nephew (NYSE:SNN; LSE:SN), the global medical technology business, is pleased to announce exciting new data from Professor Amit Gefen and his research group published in the International Wound Journal,1 demonstrating the pressure injury prevention mechanism of action of ALLEVYN COMPLETE CARE Foam Dressing and its ability to absorb and dissipate friction and shear forces.
Mesa Laboratories, Inc. to Announce Second Quarter Results on November 6, 2025LAKEWOOD, Colo., Oct. 03, 2025 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (
NASDAQ:MLAB) will issue a press release with financial results for the second quarter of fiscal year 2026 following market close on Thursday, November 6, 2025.
Banco Santander Chile: Third Quarter 2025 Analyst and Investor Webcast / Conference CallSANTIAGO, Chile, Oct. 03, 2025 (GLOBE NEWSWIRE) -- You are cordially invited to participate in Banco Santander Chile's (
NYSE: BSAC) conference call-webcast on Wednesday November 5, 2025, at 10.00 AM NY time (12.00pm Chile time) where we will discuss 3Q 2025 financial results. The Bank's Officers participating in the conference call are: Patricia Pérez, CFO, Cristian Vicuña, Chief Strategy Officer & Head of IR and Lorena Palomeque, Economist. A question and answer session will follow the presentation.
PUBMATIC CLASS ACTION REMINDER: Bragar Eagel & Squire, P.C. Reminds Investors of the Class Action Filed Against PubMatic and Encourages Investors to Contact the FirmBragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In PubMatic (PUBM) To Contact Him Directly To Discuss Their Options
SELECTQUOTE (SLQT) DEADLINE REMINDER: Bragar Eagel & Squire, P.C. Reminds SelectQuote of the October 10th Deadline and Urges Investors to Contact the FirmBragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In SelectQuote (SLQT) To Contact Him Directly To Discuss Their Options
Carestream NDT Expands Bendable Product Line With New INDUSTREX HPX-ARC 1043 PH Digital SolutionFlexible, high-resolution detector improves imaging in hard-to-reach spaces—now available in a larger size
National Performance Group Recognizes 16 Intermountain Health Hospitals for High Quality Patient Care DeliverySixteen Intermountain Health hospitals have recognized with Vizient’s 2025 Bernard A. Birnbaum, MD for high-quality care
CCH Holdings Ltd Announces Pricing of Initial Public Offering BUKIT MERTAJAM, MALAYSIA, Oct. 03, 2025 (GLOBE NEWSWIRE) -- CCH Holdings Ltd (the “Company”), a Malaysia-based specialty hotpot restaurant chain, today announced the pricing of its initial public offering (the “Offering”) of 1,250,000 ordinary shares at a public offering price of US$4.00 per ordinary share, for total gross proceeds of US$5,000,000, before deducting estimated underwriting discounts, non-accountable expense allowance, and estimated offering expenses payable by the Company. The ordinary shares have been approved for listing on the Nasdaq Capital Market and are expected to commence trading on October 3, 2025, under the ticker symbol “CCHH”.
ALTIMMUNE CLASS ACTION REMINDER: Bragar Eagel & Squire, P.C. Reminds Investors of October 6th Deadline and Urges Investors to Contact the FirmBragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Altimmune (ALT) To Contact Him Directly To Discuss Their Options
MESA LABS DECLARES QUARTERLY DIVIDENDLakewood, Colo., Oct. 03, 2025 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (
NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock. The dividend will be payable on December 15, 2025, to shareholders of record at the close of business on November 28, 2025.
Visa Lighting® Expands Cove-Inspired Harmony Line with 11 New ModelsAward-Winning Overbed Design Expands to Behavioral Health & General Use Models & More Sizes
Sysco’s Presents Southern Smoke Festival 2025 in Ongoing Commitment to Community and CustomersJoin over 85 top chefs at delicious Houston charity event aimed at raising funds to help our food & beverage community overcome crises
Luke Bryan and Bayer discuss the Take Care, Now campaign With YourUpdateTV10 Years of Supporting Rural America: Bayer and Luke Bryan Team Up with Feeding America® to Tackle Hunger with “Take Care, Now” Campaign
Parsons Honored as One of Glassdoor’s Best-Led CompaniesCHANTILLY, Va., Oct. 03, 2025 (GLOBE NEWSWIRE) -- Parsons Corporation announced today that it has been recognized by Glassdoor, an online community for workplace conversations, with a mission to build healthier, more transparent work communities for all, as one of the Best-Led Companies. The recognition is based on employee reviews and ratings published on Glassdoor in the previous year.
Antimony Market in The U.S. Projected To Grow Significantly as Critical Minerals are Becoming Vital Across Many SectorsPALM BEACH, Fla., Oct. 03, 2025 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - The global Antimony market is expected to continue the substantial growth it has seen in recent years. A report from Fortune Business Insights said that: “The global antimony market size was USD 1.01 billion in 2023 and is projected to grow from USD 1.08 billion in 2024 to USD 1.78 billion by 2032, exhibiting a CAGR of 6.5% during the forecast period. Asia Pacific dominated the antimony market with a market share of 64.36% in 2023. Moreover, the antimony market in the U.S. is projected to grow significantly, reaching an estimated value of USD 106.57 million by 2032, driven by the growing demand for OSHA regulated flame retardant clothing.” The report continued: “Antimony also called as stibnite (Sb) is a silver-grey chemical element with a silky, glossy surface. At ambient temperature, it is stable, but when heated, it interacts with oxygen to generate stibnite trioxide (Sb2O3). It has a melting point of 630°C and a density of 6.697 g/cm3 despite its low melting point. It is extremely rare in the Earth's crust, with only 0.4 parts per million (ppm) in the upper crust. It can be found in over 100 different mineral species, often combined with other elements, including mercury, silver, and gold. Stibnite is the most common ore material (Sb2S3). In 2011, 2014, and 2017, it was on the EU's list of key raw commodities. Active Companies in the mining industry this week include Xtra Energy Corporation (OTCID: XTPT), Dateline Resources Limited (OTCQB: DTREF), Teck Resources Limited (
NYSE: TECK), Nova Minerals Limited (
NASDAQ: NVA), Critical Metals Corp. (
NASDAQ: CRML).
Coherus Oncology Announces Poster Presentation at the 40th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)– CHS-114, an anti-CCR8 cytolytic antibody, will also be featured in SITC’s upcoming webinar series “Targets for Cancer IO: A Deep Dive” on October 22, 2025 –
Candel Therapeutics to Present at the SITC 2025 Annual MeetingNEEDHAM, Mass., Oct. 03, 2025 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer, today announced the Company will present insights from its enLIGHTEN™ Discovery Platform, and additional data from the CAN-2409 (aglatimagene besadenovec) program in non-small cell lung cancer (NSCLC), through two accepted poster presentations at the Society for Immunotherapy of Cancer’s (SITC) 40th Anniversary Annual Meeting, taking place November 5-9, 2025 in National Harbor, Maryland.
ALX Oncology to Present Updated Data from Phase 2 ASPEN-06 Trial, Highlighting CD47 Expression as a Predictive Biomarker in HER2+ Gastric Cancer, at 40th Society for Immunotherapy of Cancer (SITC) Annual MeetingSOUTH SAN FRANCISCO, Calif., Oct. 03, 2025 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc., (“ALX Oncology” or “the Company”) (Nasdaq: ALXO), a clinical-stage biotechnology company advancing a pipeline of novel therapies designed to treat cancer and extend patients’ lives, today announced updated data from its Phase 2 ASPEN-06 (NCT05002127) trial will be presented during a poster session at the Society for Immunotherapy of Cancer (SITC) 40th Annual Meeting taking place November 5–9, 2025, in National Harbor, Maryland. The Phase 2 trial evaluated evorpacept, the Company’s lead therapeutic candidate, in combination with HERCEPTIN® (trastuzumab), CYRAMZA® (ramucirumab) and paclitaxel, for patients with previously treated HER2-positive advanced gastric cancer (GC) and gastroesophageal junction (GEJ) cancer.
Antimony Spot Price Has Yet Again Achieved a New All-Time High as Critical Minerals Demand JumpsPALM BEACH, Fla., Oct. 03, 2025 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - Antimony is vital for many industries, including batteries, solar panels, flame retardants, and ammunition. Antimony sulfide, or Stibnite, is the principal ore of antimony and is mainly used in all these sectors. The U.S. depends almost entirely on imports, mainly from China, to meet its needs. Antimony’s demand has risen due to increasing industrial use and China’s dominance in production. The silver white metal is crucial in solar panels. It makes perovskite solar cells work better by helping them absorb more light and convert energy more effectively. It also enhances thermal stability, helping panels endure extreme conditions. A report from CarbonCredits.com, a source for carbon news, said: “Research and Markets revealed that the global demand for antimony is projected to grow from $2.5 billion in 2024 to $3.5 billion by 2030, at a CAGR of 6.2%. Additionally, the U.S. antimony market is expected to expand significantly, reaching an estimated value of USD 106.57 million by 2032. This growth primarily be driven by the rising demand for OSHA-regulated flame-retardant clothing. Other demand drivers like lead-acid batteries, electronics and plastics, etc. will also push future demand of antimony.” Active Companies in the mining industry this week include Xtra Energy Corporation (OTCID: XTPT), United States Antimony Corporation (NYSE American: UAMY), Perpetua Resources Corp. (
NASDAQ: PPTA), MP Materials Corp. (
NYSE: MP), Lithium Americas Corp. (
NYSE: LAC) (TSX: LAC).
California Resources Corporation Schedules Third Quarter 2025 Earnings Conference CallLONG BEACH, Calif., Oct. 03, 2025 (GLOBE NEWSWIRE) -- California Resources Corporation (
NYSE: CRC) plans to release its third quarter 2025 financial results on Tuesday, November 4th after market close. The Company will hold a conference call to discuss these financial results on Wednesday, November 5th at 1:00 p.m. Eastern Time (10:00 a.m. Pacific Time).
STMicroelectronics announces timing for third quarter 2025 earnings release and conference callSTMicroelectronics announces timing for third quarter 2025 earnings release and conference call
Xilio Therapeutics Announces Upcoming Presentations at the Society for Immunotherapy of Cancer (SITC) 40th Annual MeetingWALTHAM, Mass., Oct. 03, 2025 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies for people living with cancer, today announced multiple upcoming poster presentations at the Society for Immunotherapy of Cancer (SITC) 40th Annual Meeting, taking place from November 6-9, 2025 at the Gaylord National Convention Center in National Harbor, Maryland.
